Evidence map›Paper›PMID 21785735›Full record

ReviewNeural plasticity2011

Maturation of the GABAergic transmission in normal and pathologic motoneurons.

Anne-Emilie Allain, Hervé Le Corronc, Alain Delpy, William Cazenave, Pierre Meyrand, Pascal Legendre, Pascal Branchereau

Open access · goldAbstract readReview
In one paragraph

Review in Neural plasticity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Chloride Homeostasis in Developing Motoneurons.Advances in neurobiology · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Anne-Emilie AllainInstitut de Neurosciences Cognitives et Intégratives d'Aquitaine (INCIA), Université de Bordeaux et CNRS-UMR 5287, avenue des Facultés, 4ème étage Est, 33405 Talence, France.
Hervé Le Corronc
Alain Delpy
William Cazenave
Pierre Meyrand
Pascal Legendre
Pascal Branchereau
Centre National de la Recherche Scientifique · FRUniversité de Bordeaux · FRInserm · FRInstitut de Neurosciences Cognitives et Intégratives d’Aquitaine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

γ-aminobutyric acid (GABA) acting on Cl(-)-permeable ionotropic type A (GABA(A)) receptors (GABA(A)R) is the major inhibitory neurotransmitter in the adult central nervous system of vertebrates. In immature brain structures, GABA exerts depolarizing effects mostly contributing to the expression of spontaneous activities that are instructive for the construction of neural networks but GABA also acts as a potent trophic factor. In the present paper, we concentrate on brainstem and spinal motoneurons that are largely targeted by GABAergic interneurons, and we bring together data on the switch from excitatory to inhibitory effects of GABA, on the maturation of the GABAergic system and GABA(A)R subunits. We finally discuss the role of GABA and its GABA(A)R in immature hypoglossal motoneurons of the spastic (SPA) mouse, a model of human hyperekplexic syndrome.

Indexed as

AdultAmyotrophic Lateral SclerosisAnimalsCentral Nervous SystemChloridesgamma-Aminobutyric AcidGlycineHumansIon TransportMiceMotor NeuronsNerve Tissue ProteinsRatsReceptors, GABAReceptors, GlycineSynaptic TransmissionChloridesgamma-Aminobutyric AcidGlycineNerve Tissue ProteinsReceptors, GABAReceptors, Glycine

Identifiers

PMID21785735
PMCPMC3140191
OpenAlexW2040992962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.